Effamall Insights More
      China’s Vitamin Market Holds Firm but Strengthens as Folic Acid Prices Jump
      China’s Vitamin Market Holds Firm but Strengthens as Folic Acid Prices Jump
      Vitamin 11-07 17:40
      China’s Amino Acid Market: Lysine, Methionine, and Tryptophan Suffer a Slight Price Erosion Amid Muted Market Activity
      China’s Amino Acid Market: Lysine, Methionine, and Tryptophan Suffer a Slight Price Erosion Amid Muted Market Activity
      Amino Acid 11-07 17:38
      Dicalcium Phosphate Market Strengthens, While Sodium Bicarbonate and Whey Powder Edge Down
      Dicalcium Phosphate Market Strengthens, While Sodium Bicarbonate and Whey Powder Edge Down
      Minerals 11-07 17:25
      Brother Enterprises Holding Achieves Q3 2025 Net Profits of RMB 36.90 Million, Surging by 100.30% Year-over-Year
      Brother Enterprises Holding Achieves Q3 2025 Net Profits of RMB 36.90 Million, Surging by 100.30% Year-over-Year
      Enterprise News 11-06 16:01
      BASF Group Releases Q3 2025 Financial Results
      BASF Group Releases Q3 2025 Financial Results
      Enterprise News 11-06 16:00
      Hangzhou Tigermed Consulting Achieves Q3 2025 Net Profits of RMB 637 Million, Up 98.73% Year-over-Year
      Hangzhou Tigermed Consulting Achieves Q3 2025 Net Profits of RMB 637 Million, Up 98.73% Year-over-Year
      Enterprise News 11-06 15:59
      New Hope Liuhe Reports Q3 2025 Net Profits of RMB 5.126 Million, Down 99.63% Year-over-Year
      New Hope Liuhe Reports Q3 2025 Net Profits of RMB 5.126 Million, Down 99.63% Year-over-Year
      Enterprise News 11-06 15:57
      Jiangxi Tianxin Pharmaceutical Reports Q3 2025 Net Profits of RMB 104 Million, Down 30.15% Year-over-Year
      Jiangxi Tianxin Pharmaceutical Reports Q3 2025 Net Profits of RMB 104 Million, Down 30.15% Year-over-Year
      Enterprise News 11-06 15:56
      CSPC Pharmaceutical Group Reports Net Losses of RMB 21.30 Million in Q3 2025, Down 1025.45% Year-over-Year
      CSPC Pharmaceutical Group Reports Net Losses of RMB 21.30 Million in Q3 2025, Down 1025.45% Year-over-Year
      Enterprise News 11-06 15:50
      Yifan Pharmaceutical Reports Q3 2025 Net Profits of RMB 84.14 Million, Down 25.64% Year-over-Year
      Yifan Pharmaceutical Reports Q3 2025 Net Profits of RMB 84.14 Million, Down 25.64% Year-over-Year
      Enterprise News 11-06 15:49
        All Type
        Loading...
        Loading...